This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1996 May;55(5):273-5.

doi: 10.1136/ard.55.5.273.

Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists

W Hassan¹

Affiliations

PMID: 8660097
PMCID: PMC1010158
DOI: 10.1136/ard.55.5.273

Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists

W Hassan. Ann Rheum Dis. 1996 May.

. 1996 May;55(5):273-5.

doi: 10.1136/ard.55.5.273.

Author

W Hassan¹

Affiliation

¹ Department of Rheumatology, District General Hospital, Sunderland, United Kingdom.

PMID: 8660097
PMCID: PMC1010158
DOI: 10.1136/ard.55.5.273

No abstract available

PubMed Disclaimer

Similar articles

Methotrexate hepatotoxicity: what is the evidence?
Ahern MJ, Smith MD, Roberts-Thomson PJ. Ahern MJ, et al. Inflamm Res. 1998 Apr;47(4):148-51. doi: 10.1007/s000110050307. Inflamm Res. 1998. PMID: 9628257 Review. No abstract available.
Methotrexate and psoriasis in the era of new biologic agents.
Saporito FC, Menter MA. Saporito FC, et al. J Am Acad Dermatol. 2004 Feb;50(2):301-9. doi: 10.1016/s0190-9622(03)00803-x. J Am Acad Dermatol. 2004. PMID: 14726893 Review. No abstract available.
Methotrexate use in psoriasis and psoriatic arthritis.
Cuellar ML, Espinoza LR. Cuellar ML, et al. Rheum Dis Clin North Am. 1997 Nov;23(4):797-809. doi: 10.1016/s0889-857x(05)70361-6. Rheum Dis Clin North Am. 1997. PMID: 9361156 Review.
Comment on: Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Lynch M, Kirby B. Lynch M, et al. Rheumatology (Oxford). 2010 Jan;49(1):196-7; author reply 197-8. doi: 10.1093/rheumatology/kep330. Epub 2009 Oct 25. Rheumatology (Oxford). 2010. PMID: 19858119 No abstract available.
Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
Lewis JH. Lewis JH. J Rheumatol. 1997 Aug;24(8):1459-60. J Rheumatol. 1997. PMID: 9263133 No abstract available.

See all similar articles

Cited by

Hepatotoxicity related to antirheumatic drugs.
Aithal GP. Aithal GP. Nat Rev Rheumatol. 2011 Mar;7(3):139-50. doi: 10.1038/nrrheum.2010.214. Epub 2011 Jan 25. Nat Rev Rheumatol. 2011. PMID: 21263458 Review.
Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress.
Kalemci S, Topal Y, Celik SY, Yilmaz N, Beydilli H, Kosar MI, Dirican N, Altuntas I. Kalemci S, et al. Exp Ther Med. 2015 Aug;10(2):503-507. doi: 10.3892/etm.2015.2542. Epub 2015 Jun 3. Exp Ther Med. 2015. PMID: 26622344 Free PMC article.
Evidence-based therapy for cutaneous sarcoidosis.
Doherty CB, Rosen T. Doherty CB, et al. Drugs. 2008;68(10):1361-83. doi: 10.2165/00003495-200868100-00003. Drugs. 2008. PMID: 18578557 Review.
Psoriasis in children: a guide to its diagnosis and management.
Leman J, Burden D. Leman J, et al. Paediatr Drugs. 2001;3(9):673-80. doi: 10.2165/00128072-200103090-00005. Paediatr Drugs. 2001. PMID: 11688598 Review.

References

1. Acta Pathol Microbiol Scand A. 1977 Jul;85(4):511-8 - PubMed
1. Ann Intern Med. 1963 Jun;58:909-25 - PubMed
1. Clin Pharm. 1986 Jun;5(6):503-8 - PubMed
1. Br J Dermatol. 1987 Sep;117(3):311-6 - PubMed
1. J Am Acad Dermatol. 1988 Jul;19(1 Pt 1):145-56 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information